▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Chardan Healthcare Acquisition in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $6.67.
The current consensus among 0 polled investment analysts is to n/a stock in Chardan Healthcare Acquisition. This rating has held steady since September 2020, when it changed from a Buy consensus rating.
Chardan Healthcare Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was founded in 2017 and is based in New York, New York.